Clinical Trial Update: Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ezetimibe plus simvastatin versus simvastatin alone in hypercholesterolemia with coronary risk factors; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Hypercholesterolemia

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)
• ezetimibe plus simvastatin

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia, Atherosclerosis | Phase 4 | Status: TERMINATED